Successful Treatment of Chronic Eosinophilic Pneumonia with Anti-IgE Therapy
Journal of Korean Medical Science
;
: 1261-1264, 2012.
Article
in English
| WPRIM
| ID: wpr-164984
ABSTRACT
Anti-IgE therapy, using recombinant humanized anti-IgE antibodies, is clinically effective in patients with eosinophil-related disorders such as allergic asthma, allergic rhinitis, and chronic urticaria. Chronic eosinophilic pneumonia tends to respond promptly to systemic corticosteroid therapy, however; relapses are common following corticosteroid tapering. We treated two patients (17- and 19-yr-old males) of chronic eosinophilic pneumonia whose symptoms were cough and dyspnea on exertion. The symptoms were recurrent while tapering off corticosteroid. They were treated with anti-IgE antibody without recurrence for 2 yr and 15 months. Here, we first describe clinical experience of the 2 cases of chronic eosinophilic pneumonia.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Pulmonary Eosinophilia
/
Tomography, X-Ray Computed
/
Antibodies, Anti-Idiotypic
/
Adrenal Cortex Hormones
/
Cough
/
Dyspnea
Limits:
Adolescent
/
Humans
/
Male
Language:
English
Journal:
Journal of Korean Medical Science
Year:
2012
Type:
Article
Similar
MEDLINE
...
LILACS
LIS